Search - Prime Therapeutics

366 Results for GLP-1 Pipeline Update

A preview of Prime Therapeutics’ presence at AMCP Nexus 2024

Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...

PA Sub-Categories: GLP-1 Technology Specialty drugs Products Prime Article: Perspectives
Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025

Prime to present seven studies and receive the 2024 JMCP Award for Excellence

PA Sub-Categories: GLP-1 Technology Prime Article: Press Releases
GLP-1 Resources

GLP-1 year two cost effectiveness study abstract
Prime’s Pat Gleason joins panel on GLP-1 drugs and “Food is Medicine” on Capitol Hill

The event emphasizes additional measures for obesity therapy.

PA Sub-Categories: GLP-1 Prime Article: Stories